Hafiz et al., 2011 - Google Patents
Contemporary Clinical Outcomes of Primary Percutaneous Coronary Intervention in Elderly versus Younger Patients Presenting with Acute ST‐Segment Elevation …Hafiz et al., 2011
- Document ID
- 12353426970107936502
- Author
- Hafiz A
- Jan M
- Mori N
- Gupta A
- Bajwa T
- Allaqaband S
- Publication year
- Publication venue
- Journal of interventional cardiology
External Links
Snippet
Background: Primary percutaneous coronary intervention (PPCI) is the choice reperfusion strategy for acute ST‐segment elevation myocardial infarction (STEMI). However, data on PPCI in elderly patients are sparse. This study determined clinical outcome post‐PPCI in …
- 206010000891 Acute myocardial infarction 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hafiz et al. | Contemporary Clinical Outcomes of Primary Percutaneous Coronary Intervention in Elderly versus Younger Patients Presenting with Acute ST‐Segment Elevation Myocardial Infarction | |
| Byrne et al. | 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG | |
| Kelbæk et al. | Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial | |
| Kastrati et al. | Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial | |
| Varghese et al. | Non-ST elevation acute coronary syndrome in women and the elderly: recent updates and stones still left unturned | |
| Hermiller et al. | Benefits and risks of extended dual antiplatelet therapy after everolimus-eluting stents | |
| Gaine et al. | Pulmonary arterial hypertension: tailoring treatment to risk in the current era | |
| Hook et al. | Selecting lung transplant candidates: where do current guidelines fall short? | |
| Kernan et al. | Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke | |
| Flynn et al. | Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial | |
| Montalescot et al. | Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial | |
| Hochman et al. | Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry | |
| Writing Committee Members et al. | ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) | |
| Sood et al. | Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT | |
| Ben-Gal et al. | Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial | |
| Tousek et al. | Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study | |
| Hussain et al. | The ability to achieve complete revascularization is associated with improved in‐hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators | |
| Capodanno et al. | Validating the EXCEL hypothesis: A propensity score matched 3‐year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score≤ 32 | |
| Lin et al. | Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: a report from the ET-CHD registry | |
| Schulman | Antiplatelet therapy in non–ST-segment elevation acute coronary syndromes | |
| Kim et al. | Comparison between beta-blockers with angiotensin-converting enzyme inhibitors and beta-blockers with angiotensin II type I receptor blockers in ST-segment elevation myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents | |
| Harskamp et al. | Antithrombotic therapy in patients with atrial fibrillation after acute coronary syndromes or percutaneous intervention | |
| Jamal et al. | Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention | |
| Li et al. | Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution | |
| Kovacic et al. | Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary “real‐world” practice |